| D007223 |
Infant |
A child between 1 and 23 months of age. |
Infants |
|
| D007225 |
Infant Food |
Food processed and manufactured for the nutritional health of children in their first year of life. |
Food, Infant,Foods, Infant,Infant Foods |
|
| D007227 |
Infant Nutritional Physiological Phenomena |
Nutritional physiology of children from birth to 2 years of age. |
Infant Nutrition Physiology,Nutrition Physiology, Infant,Complementary Feeding,Infant Nutritional Physiological Phenomenon,Infant Nutritional Physiology,Supplementary Feeding,Complementary Feedings,Feeding, Complementary,Feeding, Supplementary,Feedings, Complementary,Feedings, Supplementary,Nutritional Physiology, Infant,Physiology, Infant Nutrition,Physiology, Infant Nutritional,Supplementary Feedings |
|
| D008895 |
Milk, Human |
Milk that is produced by HUMAN MAMMARY GLANDS. |
Breast Milk,Human Milk,Milk, Breast |
|
| D010188 |
Exocrine Pancreatic Insufficiency |
A malabsorption condition resulting from greater than 10% reduction in the secretion of pancreatic digestive enzymes (LIPASE; PROTEASES; and AMYLASE) by the EXOCRINE PANCREAS into the DUODENUM. This condition is often associated with CYSTIC FIBROSIS and with chronic PANCREATITIS. |
Pancreatic Insufficiency,Exocrine Pancreatic Insufficiencies,Insufficiencies, Exocrine Pancreatic,Insufficiencies, Pancreatic,Insufficiency, Exocrine Pancreatic,Insufficiency, Pancreatic,Pancreatic Insufficiencies,Pancreatic Insufficiencies, Exocrine,Pancreatic Insufficiency, Exocrine |
|
| D003550 |
Cystic Fibrosis |
An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. |
Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases |
|
| D006128 |
Growth |
Gradual increase in the number, the size, and the complexity of cells of an individual. Growth generally results in increase in ORGAN WEIGHT; BODY WEIGHT; and BODY HEIGHT. |
|
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D057487 |
Enzyme Therapy |
The use of enzymes to correct metabolic and physiological processes. |
Enzymotherapy,Systemic Enzyme Therapy,Enzyme Therapies,Enzyme Therapies, Systemic,Enzyme Therapy, Systemic,Enzymotherapies,Systemic Enzyme Therapies,Therapies, Enzyme,Therapies, Systemic Enzyme,Therapy, Enzyme,Therapy, Systemic Enzyme |
|